Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies
Frontiers in Immunology · 08.07.2026 · 17
DOI: 10.3389/fimmu.2026.1907428 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Immunology, online erschienen am 08.07.2026. Verfasst von Pupu Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Zhengzhou Key Laboratory of Lipid Metabolism and Precision Diagnosis & Treatment in Oncology, Oncology Department, The Fifth Affiliated Hospital of Z…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(2021) 8:e711-22. doi: 10.1016/s2352-3026(21)00238-6 30. Yunlin Z, Ruchi PP, Ki Hyun K, Hyungwoo C, Jae-Cheol J, Seong Hyun J, et al. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on-and off-rates against non-Hodgkin lymphoma: a first-in-human study. (2023) 22:200. doi: 10.1186/s12943-023-01886-9].It should be [23,24,26,27,28,29,30,31,32,33 23 The original version of this article has been updated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhengzhou Key Laboratory of Lipid Metabolism and Precision Diagnosis & Treatment in Oncology, Oncology Department, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou, China.
Zitieren
APA
Li, P., Xue, X., & Zhang, Z. (2026). Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1907428
Vancouver
Li P, Xue X, Zhang Z. Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1907428
BibTeX
@article{Li2026,
author = {Li, Pupu and Xue, Xia and Zhang, Zisen},
title = {Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1907428}
}
EUVIMED